PFIC and Alagille Syndrome Studies

James Squires, MD, University of Pittsburgh, discusses recent data regarding Bylvay (odevixibat) in patients with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome.   PFIC is a heterogeneous group of autosomal recessive disorders of...

NDA Submission of Paltusotine for Acromegaly

Alan Krasner, MD, Chief Medical Officer of Crinetics Pharmaceuticals, discusses the new drug application (NDA) submission of paltusotine for treating acromegaly.   Acromegaly is a rare hormonal disorder resulting from the overproduction of growth hormone in the...